MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    DYT16/PRKRA founder mutation causes childhood-onset generalized dystonia in a family from southern Italy

    M. Quadri, S. Olgiati, M. Sensi, F. Gualandi, E. Groppo, V. Rispoli, J. Graafland, G.J. Breedveld, G. Fabbrini, A. Berardelli, V. Bonifati (Rotterdam, Netherlands)

    Objective: To describe a family with three siblings affected by the combination of dystonia and parkinsonism, as a resulting phenotype of recessive PRKRA mutation. Background:…
  • 2016 International Congress

    The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients

    N. Ongun, C. Erdogan, E. Degirmenci, L.S. Bir (Denizli, Turkey)

    Objective: To determine the effect of nutritional status in 6 weeks time on depression, anxiety and quality of life in Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    AntiParkinsonian effects of the “radiprodil and tozadenant” combination in MPTP-treated marmosets

    A. Michel, J.M. Nicolas, S. Rose, M. Jackson, P. Colman, W. Briône, D. Sciberras, P. Muglia, D. Scheller, M. Citron, P. Downey (Braine L'Alleud, Belgium)

    Objective: Investigate a combination of two clinically tested drugs, the NR2B antagonist Radiprodil and the A2A antagonist Tozadenant in unilaterally 6-OHDA-lesioned rats and in MPTP-treated…
  • 2016 International Congress

    Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease

    C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky (Rio de Janeiro, Brazil)

    Objective: This study aims to carry out validity and reliability of the Test dEvaluation des Membres Superieurs Des Personnes Agees (TEMPA) in patients with PD.…
  • 2016 International Congress

    New therapeutic algorithm for abnormal posture in Parkinson’s disease and related disorders

    Y. Mukai, Y. Furusawa, Y. Aoshima, H. Todo, Y. Hama, C. Matsumoto, N. Wakasugi, Y. Mizuno, T. Kawazoe, Y. Saitoh, T. Sakamoto, M. Murata (Tokyo, Japan)

    Objective: To establish the simple therapeutic algorithm for abnormal posture in Parkinson's disease (PD) or related disorders. Background: Camptocormia or dropped head are sometimes accompanied…
  • 2016 International Congress

    Experience with utilization of rytary in the clinical setting

    Y. Kianirad, T. Simuni, C. Zadikoff, D. Bega, M. Afshari, S. Jonnalagadda (Chicago, IL, USA)

    Objective: To explore the utilization and tolerability of Rytary in the clinical setting. Background: Rytary is a novel extended-release carbidopa-levodopa (CD-LD) formulation that was approved…
  • 2016 International Congress

    Motor phenotype classification in moderate to advanced PD: Data from the BioFIND study

    L. Luo, H.F. Andrews, J.G. Goldman, R.N. Alcalay, T. Xie, P. Tuite, C. Henchcliffe, P. Hogarth, A. Amara, S. Frank, A. Rudolph, C. Casaceli, K. Gwinn, M. Sutherland, C. Kopil, L. Vincent, M. Frasier, U.J. Kang (New York, NY, USA)

    Objective: To evaluate the validity of motor phenotype classification in response to dopaminergic agents in moderate to advanced Parkinson's disease (PD) patients enrolled in the…
  • 2016 International Congress

    Fox insight wear ecosystem: using mobile technology and cloud-based computing to support PD research

    I. Feldman, M. Afek, L. Bataille (Gedera, Israel)

    Objective: To enable a simple strategy for the continuous collection and analysis of sensory data from Parkinson's disease (PD) patients that can increase the effectiveness…
  • 2016 International Congress

    Changes of speech after neurostimulation for Parkinson’s disease with early fluctuations: A 2-years randomized controlled trial (earlystim-speech)

    S. Pinto, A. Nebel, R. Espesser, J. Rau, P. Maillochon, O. Krack, K. Knudsen, A. Ghio, O. Niebuhr, Y. Agid, M. Schüpbach, G. Deuschl (Aix-en-Provence, France)

    Objective: To assess the effect of subthalamic deep brain stimulation (STN-DBS) on speech in Parkinson's disease patients with early fluctuations and dyskinesia. Background: The effect…
  • 2016 International Congress

    RE-024: A potential phosphopantothenate replacement therapy in 2 patients with pantothenate kinase-associated neurodegeneration (PKAN)

    P. Roa, P. Stoeter, E. Perez, M. Santana (Santo Domingo, Dominican Republic)

    Objective: To evaluate the safety and potential efficacy of RE-024 in open treatment of 2 patients with PKAN. Background: PKAN is an autosomal recessive, neurodegenerative…
  • « Previous Page
  • 1
  • …
  • 354
  • 355
  • 356
  • 357
  • 358
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley